YAHOO FINANCE CHARTBOOK 44 charts that explain markets and the economy right now Frankfurt - Delayed Quote • EUR Ultimovacs ASA (7UM.F) Follow Compare 0.1742 -0.0036 (-2.02%) At close: January 31 at 3:29:01 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 7UM.F 1D 5D -2.24% 1M -8.03% 3M 22.85% 6M -74.83% YTD -8.03% 1Y -98.59% 5Y -96.58% All -94.35% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: 7UM.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Ultimovacs ASA (FRA:7UM) Q4 2024 Earnings Call Highlights: Strategic Merger and Financial Challenges Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update Ultimovacs ASA: Invitation to fourth quarter 2024 results webcast presentation Ultimovacs ASA: Notification of major holdings Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 - CORRECTION Ultimovacs ASA: Notice of extraordinary general meeting on 9 January 2024 Key information relating to the potential subsequent repair offering to be carried out by Ultimovacs ASA Ultimovacs ASA – Mandatory notification of trade ULTIMOVACS ANNOUNCES AGREEMENT TO COMBINE ITS BUSINESS WITH ZELLUNA IMMUNOTHERAPY AND INTENTION TO LAUNCH FULLY COMMITTED PRIVATE PLACEMENT Ultimovacs ASA (FRA:7UM) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Financial ... Ultimovacs ASA Reports Third Quarter 2024 Financial Results and Provides General Business Update Related Tickers 50BA.F Bicycle Therapeutics plc 11.90 -1.65% 6XP.SG Xspray Pharma AB (publ) 2.8600 +5.93% 4YL.F Nanoform Finland Oyj 1.2100 -0.17% 471A.F aTyr Pharma, Inc. 3.5800 +3.47% IMR.F AC Immune SA 2.5200 +1.82% 5CV.F CureVac N.V. 3.6520 -1.78% CARA Cara Therapeutics, Inc. 4.8400 -3.39%